{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T05:53:48Z","timestamp":1790834028575,"version":"4.1.0"},"reference-count":88,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,10,17]],"date-time":"2016-10-17T00:00:00Z","timestamp":1476662400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1016\/j.lfs.2016.10.015","type":"journal-article","created":{"date-parts":[[2016,10,19]],"date-time":"2016-10-19T03:07:34Z","timestamp":1476846454000},"page":"121-130","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":56,"special_numbering":"C","title":["Diabetic nephropathy and endothelial dysfunction: Current and future therapies, and emerging of vascular imaging for preclinical renal-kinetic study"],"prefix":"10.1016","volume":"166","author":[{"given":"Wilson KC","family":"Leung","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parco M","family":"Siu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher WK","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.lfs.2016.10.015_bb0005","series-title":"Global Report on Diabetes","author":"World Health Organization","year":"2016"},{"key":"10.1016\/j.lfs.2016.10.015_bb0010","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.0030442","article-title":"Projections of global mortality and burden of disease from 2002 to 2030","volume":"3","author":"Mathers","year":"2006","journal-title":"PLoS Med."},{"key":"10.1016\/j.lfs.2016.10.015_bb0015","series-title":"Type 2 Diabetes: Prediction and Prevention","author":"GA","year":"2007"},{"key":"10.1016\/j.lfs.2016.10.015_bb0020","doi-asserted-by":"crossref","first-page":"106","DOI":"10.4093\/dmj.2013.37.2.106","article-title":"A systematic review of oxidative stress and safety of antioxidants in diabetes: focus on islets and their defense","volume":"37","author":"Karunakaran","year":"2013","journal-title":"Diabetes Metab. J."},{"key":"10.1016\/j.lfs.2016.10.015_bb0025","doi-asserted-by":"crossref","first-page":"216512","DOI":"10.1155\/2012\/216512","article-title":"Prevention of diabetic complications by activation of Nrf2: diabetic cardiomyopathy and nephropathy","volume":"2012","author":"Li","year":"2012","journal-title":"Exp. Diabetes Res."},{"key":"10.1016\/j.lfs.2016.10.015_bb0030","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1002\/dmrr.2460","article-title":"Tissue specific oxidative stress profile in relation to glycaemic regulation in mice","volume":"30","author":"Modak","year":"2014","journal-title":"Diabetes Metab. Res. Rev."},{"key":"10.1016\/j.lfs.2016.10.015_bb0035","doi-asserted-by":"crossref","first-page":"5695","DOI":"10.2174\/1381612811319320005","article-title":"Hyperglycemia-induced oxidative stress and its role in diabetes mellitus related cardiovascular diseases","volume":"19","author":"Fiorentino","year":"2013","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.lfs.2016.10.015_bb0040","doi-asserted-by":"crossref","first-page":"14205","DOI":"10.3748\/wjg.v20.i39.14205","article-title":"Oxidative stress, cardiolipin and mitochondrial dysfunction in nonalcoholic fatty liver disease","volume":"20","author":"Paradies","year":"2014","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.lfs.2016.10.015_bb0045","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.cellsig.2014.12.011","article-title":"Hyperglycemia enhances kidney cell injury in HIVAN through down-regulation of vitamin D receptors","volume":"27","author":"Rai","year":"2015","journal-title":"Cell. Signal."},{"key":"10.1016\/j.lfs.2016.10.015_bb0050","doi-asserted-by":"crossref","first-page":"2985","DOI":"10.1167\/iovs.15-16466","article-title":"Lipotoxicity augments glucotoxicity-induced mitochondrial damage in the development of diabetic retinopathy","volume":"56","author":"Kumar","year":"2015","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.lfs.2016.10.015_bb0055","doi-asserted-by":"crossref","first-page":"752387","DOI":"10.1155\/2014\/752387","article-title":"Oxidative stress: implications for the development of diabetic retinopathy and antioxidant therapeutic perspectives","volume":"2014","author":"Wu","year":"2014","journal-title":"Oxidative Med. Cell. Longev."},{"key":"10.1016\/j.lfs.2016.10.015_bb0060","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1016\/j.numecd.2013.05.006","article-title":"Clinical and molecular mechanisms favoring cancer initiation and progression in diabetic patients","volume":"23","author":"Sciacca","year":"2013","journal-title":"Nutr. Metab. Cardiovasc. Dis."},{"key":"10.1016\/j.lfs.2016.10.015_bb0065","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1073\/pnas.1322153111","article-title":"Endothelial cellular senescence is inhibited by liver X receptor activation with an additional mechanism for its atheroprotection in diabetes","volume":"111","author":"Hayashi","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.lfs.2016.10.015_bb0070","doi-asserted-by":"crossref","first-page":"17018","DOI":"10.1073\/pnas.0607873103","article-title":"Endothelial cellular senescence is inhibited by nitric oxide: implications in atherosclerosis associated with menopause and diabetes","volume":"103","author":"Hayashi","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.lfs.2016.10.015_bb0075","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0088391","article-title":"eNOS-dependent antisenscence effect of a calcium channel blocker in human endothelial cells","volume":"9","author":"Hayashi","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.lfs.2016.10.015_bb0080","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1124\/jpet.110.177584","article-title":"Dose-dependent modulatory effects of insulin on glucose-induced endothelial senescence in vitro and in vivo: a relationship between telomeres and nitric oxide","volume":"337","author":"Matsui-Hirai","year":"2011","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.lfs.2016.10.015_bb0085","doi-asserted-by":"crossref","first-page":"2648","DOI":"10.2337\/diabetes.51.8.2648","article-title":"Glucose increases endothelial-dependent superoxide formation in coronary arteries by NAD(P)H oxidase activation: attenuation by the 3-hydroxyl-3-methylglutaryl coenzyme A reductase inhibitor","volume":"51","author":"Christ","year":"2002","journal-title":"Diabetes"},{"key":"10.1016\/j.lfs.2016.10.015_bb0090","doi-asserted-by":"crossref","first-page":"2216","DOI":"10.1016\/j.bbadis.2013.08.006","article-title":"Endothelial dysfunction\u2014a major mediator of diabetic vascular disease","volume":"1832","author":"Sena","year":"2013","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.lfs.2016.10.015_bb0095","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000437098","article-title":"Homocysteine-induced endothelial dysfunction","volume":"67","author":"Lai","year":"2015","journal-title":"Ann. Nutr. Metab."},{"key":"10.1016\/j.lfs.2016.10.015_bb0100","series-title":"Human Physiology","author":"IF","year":"2012"},{"key":"10.1016\/j.lfs.2016.10.015_bb0105","series-title":"Essentials of Anatomy and Physiology","author":"Martini","year":"2013"},{"key":"10.1016\/j.lfs.2016.10.015_bb0110","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1038\/sj.ki.5000141","article-title":"Renal albumin absorption in physiology and pathology","volume":"69","author":"Birn","year":"2006","journal-title":"Kidney Int."},{"key":"10.1016\/j.lfs.2016.10.015_bb0115","doi-asserted-by":"crossref","DOI":"10.1681\/ASN.2015111219","article-title":"Capillary rarefaction associates with albuminuria: the Maastricht study","author":"Martens","year":"2016","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.lfs.2016.10.015_bb0120","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.mgene.2014.04.009","article-title":"Association of the endothelial nitric oxide synthase gene G894T polymorphism with the risk of diabetic nephropathy in Qassim region, Saudi Arabia\u2014A pilot study","volume":"2","author":"Mackawy","year":"2014","journal-title":"Meta. Gene."},{"key":"10.1016\/j.lfs.2016.10.015_bb0125","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0112538","article-title":"Proximal tubule dysfunction is associated with podocyte damage biomarkers nephrin and vascular endothelial growth factor in type 2 diabetes mellitus patients: a cross-sectional study","volume":"9","author":"Petrica","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.lfs.2016.10.015_bb0130","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1155\/2013\/370461","article-title":"Urinary leukotriene E4 is associated with renal function but not with endothelial function in type 2 diabetes","volume":"35","author":"Rafnsson","year":"2013","journal-title":"Dis. Markers"},{"key":"10.1016\/j.lfs.2016.10.015_bb0135","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0040427","article-title":"Effect of benfotiamine on advanced glycation endproducts and markers of endothelial dysfunction and inflammation in diabetic nephropathy","volume":"7","author":"Alkhalaf","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.lfs.2016.10.015_bb0140","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1007\/s00125-011-2415-y","article-title":"The endothelin receptor antagonist bosentan improves peripheral endothelial function in patients with type 2 diabetes mellitus and microalbuminuria: a randomized trial","volume":"55","author":"Rafnsson","year":"2012","journal-title":"Diabetologia"},{"key":"10.1016\/j.lfs.2016.10.015_bb0145","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/1475-2840-10-54","article-title":"YKL-40 levels are independently associated with albuminuria in type 2 diabetes","volume":"10","author":"R\u00f8ndbjerg","year":"2010","journal-title":"Cardiovasc. Diabetol."},{"key":"10.1016\/j.lfs.2016.10.015_bb0150","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1007\/s00467-014-2888-2","article-title":"Urinary biomarkers for early diabetic nephropathy: beyond albuminuria","volume":"30","author":"Lee","year":"2015","journal-title":"Pediatr. Nephrol."},{"key":"10.1016\/j.lfs.2016.10.015_bb0155","doi-asserted-by":"crossref","first-page":"13601","DOI":"10.1038\/srep13601","article-title":"Measures of kidney function by minimally invasive techniques correlate with histological glomerular damage in SCID mice with adriamycin-induced nephropathy","volume":"5","author":"Scarfe","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.lfs.2016.10.015_bb0160","series-title":"Handbook of Diabetes","author":"Bilous","year":"2010"},{"key":"10.1016\/j.lfs.2016.10.015_bb0165","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1097\/00004872-200501000-00004","article-title":"Endothelial function and dysfunction. Part I: Methodological issues for assessment in the different vascular beds: a statement by the Working Group on Endothelin and Endothelial Factors of the European Society of Hypertension","volume":"23","author":"Deanfield","year":"2005","journal-title":"J. Hypertens."},{"key":"10.1016\/j.lfs.2016.10.015_bb0170","first-page":"333","article-title":"Role of nitric oxide and other endothelium-derived factors","volume":"39","author":"Stankevicius","year":"2003","journal-title":"Medicina (Kaunas)"},{"key":"10.1016\/j.lfs.2016.10.015_bb0175","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1093\/ndt\/gfs516","article-title":"Chronic renal impairment and DDAH2-1151 A\/C polymorphism determine ADMA levels in type 2 diabetic subjects","volume":"28","author":"Marra","year":"2013","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.lfs.2016.10.015_bb0180","doi-asserted-by":"crossref","first-page":"878","DOI":"10.3109\/0886022X.2011.605978","article-title":"Impact of nitric oxide synthase Glu298Asp polymorphism on the development of end-stage renal disease in type 2 diabetic Egyptian patients","volume":"33","author":"El-Din Bessa","year":"2011","journal-title":"Ren. Fail."},{"key":"10.1016\/j.lfs.2016.10.015_bb0185","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1093\/ndt\/gfs536","article-title":"22-Oxacalcitriol prevents progression of endothelial dysfunction through antioxidative effects in rats with type 2 diabetes and early-stage nephropathy","volume":"28","author":"Hirata","year":"2013","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.lfs.2016.10.015_bb0190","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1097\/HJH.0b013e328349064c","article-title":"Long-term treatment with nebivolol attenuates renal damage in Zucker diabetic fatty rats","volume":"29","author":"Toblli","year":"2011","journal-title":"J. Hypertens."},{"key":"10.1016\/j.lfs.2016.10.015_bb0195","doi-asserted-by":"crossref","first-page":"F1114","DOI":"10.1152\/ajprenal.00122.2011","article-title":"Distinct cardiac and renal effects of ETA receptor antagonist and ACE inhibitor in experimental type 2 diabetes","volume":"301","author":"Zoja","year":"2011","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"10.1016\/j.lfs.2016.10.015_bb0200","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1159\/000366169","article-title":"Ramipril lowers plasma FGF-23 in patients with diabetic nephropathy","volume":"40","author":"Yilmaz","year":"2014","journal-title":"Am. J. Nephrol."},{"key":"10.1016\/j.lfs.2016.10.015_bb0205","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1093\/ndt\/gfu255","article-title":"A prospective study of multiple protein biomarkers to predict progression in diabetic chronic kidney disease","volume":"29","author":"Agarwal","year":"2014","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.lfs.2016.10.015_bb0210","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/S0272-6386(97)90004-4","article-title":"Endothelins in the normal and diseased kidney","volume":"29","author":"Kohan","year":"1997","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.lfs.2016.10.015_bb0215","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1007\/s00467-012-2316-4","article-title":"Endothelin antagonists in hypertension and kidney disease","volume":"28","author":"Meyers","year":"2013","journal-title":"Pediatr. Nephrol."},{"key":"10.1016\/j.lfs.2016.10.015_bb0220","doi-asserted-by":"crossref","first-page":"45","DOI":"10.2174\/157016107779317161","article-title":"Endothelin-1-induced signaling pathways in vascular smooth muscle cells","volume":"5","author":"Bouallegue","year":"2007","journal-title":"Curr. Vasc. Pharmacol."},{"key":"10.1016\/j.lfs.2016.10.015_bb0225","doi-asserted-by":"crossref","first-page":"3517","DOI":"10.2337\/diabetes.51.12.3517","article-title":"Endothelin contributes to basal vascular tone and endothelial dysfunction in human obesity and type 2 diabetes","volume":"51","author":"Mather","year":"2002","journal-title":"Diabetes"},{"key":"10.1016\/j.lfs.2016.10.015_bb0230","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1007\/BF00403325","article-title":"Elevated plasma endothelin in patients with diabetes mellitus","volume":"33","author":"Takahashi","year":"1990","journal-title":"Diabetologia"},{"key":"10.1016\/j.lfs.2016.10.015_bb0235","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1161\/01.CIR.97.8.752","article-title":"Endothelin-A receptor antagonist-mediated vasodilatation is attenuated by inhibition of nitric oxide synthesis and by endothelin-B receptor blockade","volume":"97","author":"Verhaar","year":"1998","journal-title":"Circulation"},{"issue":"2002","key":"10.1016\/j.lfs.2016.10.015_bb0240","first-page":"2112","article-title":"Insulin sensitivity and big ET-1 conversion to ET-1 after ETA- or ETB-receptor blockade in humans","volume":"93","author":"Ahlborg","year":"1985","journal-title":"J. Appl. Physiol."},{"key":"10.1016\/j.lfs.2016.10.015_bb0245","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/S1056-8727(01)00137-4","article-title":"The relation between plasma endothelin-1 levels and metabolic control, risk factors, treatment modalities, and diabetic microangiopathy in patients with type 2 diabetes mellitus","volume":"15","author":"Ak","year":"2001","journal-title":"J. Diabetes Complicat."},{"key":"10.1016\/j.lfs.2016.10.015_bb0250","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/S0895-7061(98)00094-6","article-title":"Role of plasma and urinary endothelin-1 in early diabetic and hypertensive nephropathy","volume":"11","author":"De Mattia","year":"1998","journal-title":"Am. J. Hypertens."},{"key":"10.1016\/j.lfs.2016.10.015_bb0255","doi-asserted-by":"crossref","first-page":"263","DOI":"10.2337\/diacare.17.4.263","article-title":"Increased urinary endothelin-1-like immunoreactivity excretion in NIDDM patients with albuminuria","volume":"17","author":"Lee","year":"1994","journal-title":"Diabetes Care"},{"key":"10.1016\/j.lfs.2016.10.015_bb0260","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.diabres.2007.12.024","article-title":"Endothelin-1 levels and albuminuria in patients with type 2 diabetes mellitus","volume":"80","author":"Zanatta","year":"2008","journal-title":"Diabetes Res. Clin. Pract."},{"key":"10.1016\/j.lfs.2016.10.015_bb0265","doi-asserted-by":"crossref","first-page":"122","DOI":"10.2174\/157016110790226606","article-title":"Role of vascular endothelial growth factor in kidney disease","volume":"8","author":"Doi","year":"2010","journal-title":"Curr. Vasc. Pharmacol."},{"key":"10.1016\/j.lfs.2016.10.015_bb0270","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1016\/j.clinbiochem.2012.07.098","article-title":"Soluble serum Klotho in diabetic nephropathy: relationship to VEGF-A","volume":"45","author":"Kacso","year":"2012","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.lfs.2016.10.015_bb0275","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1681\/ASN.2014040350","article-title":"Vascular endothelial growth factor-A165b is protective and restores endothelial glycocalyx in diabetic nephropathy","volume":"26","author":"Oltean","year":"2015","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.lfs.2016.10.015_bb0280","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s00592-008-0054-7","article-title":"Effect of pioglitazone and rosiglitazone on mediators of endothelial dysfunction, markers of angiogenesis and inflammatory cytokines in type-2 diabetes","volume":"46","author":"Vijay","year":"2009","journal-title":"Acta Diabetol."},{"key":"10.1016\/j.lfs.2016.10.015_bb0285","doi-asserted-by":"crossref","first-page":"e396","DOI":"10.1111\/j.1755-3768.2011.02114.x","article-title":"Intraocular expression of thymosin \u03b24 in proliferative diabetic retinopathy","volume":"89","author":"Wang","year":"2011","journal-title":"Acta Ophthalmol."},{"key":"10.1016\/j.lfs.2016.10.015_bb0290","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1097\/MJT.0b013e3182785ecc","article-title":"Thymosin \u03b24 attenuates early diabetic nephropathy in a mouse model of type 2 diabetes mellitus","volume":"22","author":"Zhu","year":"2015","journal-title":"Am. J. Ther."},{"key":"10.1016\/j.lfs.2016.10.015_bb0295","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1016\/j.lfs.2013.04.008","article-title":"Sulodexide improves renal function through reduction of vascular endothelial growth factor in type 2 diabetic rats","volume":"92","author":"Cha","year":"2013","journal-title":"Life Sci."},{"key":"10.1016\/j.lfs.2016.10.015_bb0300","doi-asserted-by":"crossref","first-page":"184539","DOI":"10.1155\/2013\/184539","article-title":"Uncoupling of VEGF with endothelial NO as a potential mechanism for abnormal angiogenesis in the diabetic nephropathy","volume":"2013","author":"Nakagawa","year":"2013","journal-title":"J. Diabetes Res."},{"key":"10.1016\/j.lfs.2016.10.015_bb0305","doi-asserted-by":"crossref","first-page":"13291","DOI":"10.1074\/jbc.R900010200","article-title":"The Nrf2-antioxidant response element signaling pathway and its activation by oxidative stress","volume":"284","author":"Nguyen","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.lfs.2016.10.015_bb0310","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1097\/01.mnh.0000437613.88158.d3","article-title":"Heme oxygenase-1 and acute kidney injury","volume":"23","author":"Nath","year":"2014","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"key":"10.1016\/j.lfs.2016.10.015_bb0315","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1002\/jcb.25253","article-title":"A novel danshensu derivative prevents cardiac dysfunction and improves the chemotherapeutic efficacy of doxorubicin in breast cancer cells","volume":"117","author":"Wang","year":"2016","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.lfs.2016.10.015_bb0320","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.brainres.2009.05.009","article-title":"Curcumin upregulates transcription factor Nrf2, HO-1 expression and protects rat brains against focal ischemia","volume":"1282","author":"Yang","year":"2009","journal-title":"Brain Res."},{"key":"10.1016\/j.lfs.2016.10.015_bb0325","doi-asserted-by":"crossref","first-page":"2670","DOI":"10.1016\/j.fct.2010.06.038","article-title":"Nrf2\/HO-1 signaling pathway may be the prime target for chemoprevention of cisplatin-induced nephrotoxicity by lycopene","volume":"48","author":"Sahin","year":"2010","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.lfs.2016.10.015_bb0330","doi-asserted-by":"crossref","first-page":"945901","DOI":"10.1155\/2015\/945901","article-title":"Yang\/Qi invigoration: an herbal therapy for chronic fatigue syndrome with yang deficiency?","volume":"2015","author":"Leong","year":"2015","journal-title":"Evid. Based Complement. Alternat. Med."},{"key":"10.1016\/j.lfs.2016.10.015_bb0335","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1142\/S0192415X15500780","article-title":"Effects and mechanism of combination of Rhein and danshensu in the treatment of chronic kidney disease","volume":"43","author":"Guan","year":"2015","journal-title":"Am. J. Chin. Med."},{"key":"10.1016\/j.lfs.2016.10.015_bb0340","first-page":"98","article-title":"Therapeutic effects of Chinese drugs on early renal damage of rats caused by fish bile","volume":"13","author":"Luo","year":"1993","journal-title":"Zhongguo Zhong Xi Yi Jie He Za Zhi"},{"key":"10.1016\/j.lfs.2016.10.015_bb0345","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1142\/S0192415X05003089","article-title":"The nephroprotective effects of the herbal medicine preparation, WH30+, on the chemical-induced acute and chronic renal failure in rats","volume":"33","author":"Ngai","year":"2005","journal-title":"Am. J. Chin. Med."},{"key":"10.1016\/j.lfs.2016.10.015_bb0350","first-page":"1516","article-title":"Tissue distribution in mice of danshensu from sodium danshensu and Salvia miltiorrhizainjection","volume":"36","author":"Wang","year":"2011","journal-title":"Zhongguo Zhong Yao Za Zhi"},{"key":"10.1016\/j.lfs.2016.10.015_bb0355","doi-asserted-by":"crossref","first-page":"23693","DOI":"10.1038\/srep23693","article-title":"Paeonol and danshensu combination attenuates apoptosis in myocardial infarcted rats by inhibiting oxidative stress: roles of Nrf2\/HO-1 and PI3K\/Akt pathway","volume":"6","author":"Li","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.lfs.2016.10.015_bb0360","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1016\/j.ijcard.2012.12.012","article-title":"A novel danshensu derivative confers cardioprotection via PI3K\/Akt and Nrf2 pathways","volume":"168","author":"Cui","year":"2013","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.lfs.2016.10.015_bb0365","doi-asserted-by":"crossref","first-page":"83","DOI":"10.3892\/ijmm.2016.2584","article-title":"Synergistic cardioprotective effects of danshensu and hydroxysafflor yellow A against myocardial ischemia-reperfusion injury are mediated through the Akt\/Nrf2\/HO-1 pathway","volume":"38","author":"Hu","year":"2016","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.lfs.2016.10.015_bb0370","first-page":"14793","article-title":"Danshensu protects isolated heart against ischemia reperfusion injury through activation of Akt\/ERK1\/2\/Nrf2 signaling","volume":"8","author":"Yu","year":"2015","journal-title":"Int. J. Clin. Exp. Med."},{"key":"10.1016\/j.lfs.2016.10.015_bb0375","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1007\/s00125-014-3462-y","article-title":"Epigenetic mechanisms in diabetic complications and metabolic memory","volume":"58","author":"Reddy","year":"2015","journal-title":"Diabetologia"},{"key":"10.1016\/j.lfs.2016.10.015_bb0380","doi-asserted-by":"crossref","first-page":"2563","DOI":"10.1001\/jama.287.19.2563","article-title":"Effect of intensive therapy on the microvascular complications of type 1 diabetes mellitus","volume":"287","author":"Writing Team for the Diabetes Control and Complications Trial\/Epidemiology of Diabetes Interventions and Complications Research Group","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.lfs.2016.10.015_bb0385","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1177\/1479164113500680","article-title":"Cellular and molecular mechanisms of endothelial dysfunction in diabetes","volume":"10","author":"Roberts","year":"2013","journal-title":"Diab. Vasc. Dis. Res."},{"key":"10.1016\/j.lfs.2016.10.015_bb0390","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.mce.2015.12.019","article-title":"Fatty acid induced metabolic memory involves alterations in renal histone H3K36me2 and H3K27me3","volume":"422","author":"Kumar","year":"2016","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.lfs.2016.10.015_bb0395","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.bbrc.2015.11.079","article-title":"Epigenetic regulation of glucose-stimulated osteopontin (OPN) expression in diabetic kidney","volume":"469","author":"Cai","year":"2016","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.lfs.2016.10.015_bb0400","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.2337\/db13-1251","article-title":"Evaluating the role of epigenetic histone modifications in the metabolic memory of type 1 diabetes","volume":"63","author":"Miao","year":"2014","journal-title":"Diabetes"},{"key":"10.1016\/j.lfs.2016.10.015_bb0405","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1111\/j.1440-1681.2008.05057.x","article-title":"MicroRNA-320 expression in myocardial microvascular endothelial cells and its relationship with insulin-like growth factor-1 in type 2 diabetic rats","volume":"36","author":"Wang","year":"2009","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"10.1016\/j.lfs.2016.10.015_bb0410","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1161\/CIRCULATIONAHA.110.952325","article-title":"Deregulation of microRNA-503 contributes to diabetes mellitus-induced impairment of endothelial function and reparative angiogenesis after limb ischemia","volume":"123","author":"Caporali","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.lfs.2016.10.015_bb0415","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1111\/jcmm.12576","article-title":"Long non-coding RNA MALAT1 regulates hyperglycaemia induced inflammatory process in the endothelial cells","volume":"19","author":"Puthanveetil","year":"2015","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.lfs.2016.10.015_bb0420","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.jdiacomp.2015.01.004","article-title":"Effect of paricalcitol on endothelial function and inflammation in type 2 diabetes and chronic kidney disease","volume":"29","author":"Thethi","year":"2015","journal-title":"J. Diabetes Complicat."},{"key":"10.1016\/j.lfs.2016.10.015_bb0425","doi-asserted-by":"crossref","first-page":"21414","DOI":"10.1364\/OE.17.021414","article-title":"Multispectral optoacoustic tomography (MSOT) scanner for whole-body small animal imaging","volume":"17","author":"Ma","year":"2009","journal-title":"Opt. Express"},{"key":"10.1016\/j.lfs.2016.10.015_bb0430","author":"iTheraMedical"},{"key":"10.1016\/j.lfs.2016.10.015_bb0435","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/s11307-011-0502-6","article-title":"Multispectral optoacoustic tomography of matrix metalloproteinase activity in vulnerable human carotid plaques","volume":"14","author":"Razansky","year":"2012","journal-title":"Mol. Imaging Biol."},{"key":"10.1016\/j.lfs.2016.10.015_bb0440","doi-asserted-by":"crossref","first-page":"18","DOI":"10.7150\/thno\/v01p0018","article-title":"Real-time video imaging of protease expression in vivo","volume":"1","author":"Zhu","year":"2011","journal-title":"Theranostics"}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320516306063?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320516306063?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,14]],"date-time":"2019-09-14T15:36:57Z","timestamp":1568475417000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0024320516306063"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12]]},"references-count":88,"alternative-id":["S0024320516306063"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2016.10.015","relation":{},"ISSN":["0024-3205"],"issn-type":[{"value":"0024-3205","type":"print"}],"subject":[],"published":{"date-parts":[[2016,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Diabetic nephropathy and endothelial dysfunction: Current and future therapies, and emerging of vascular imaging for preclinical renal-kinetic study","name":"articletitle","label":"Article Title"},{"value":"Life Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lfs.2016.10.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}